Documente Academic
Documente Profesional
Documente Cultură
• Osteoblasts- formation of
new bone matrix
•Osteoclasts- antagonistic
function to osteoblasts,
resorb already present
bone matrix
•Osteocytes- osteoblasts
that have become
enclosed within bone
matrix and no longer
deposit matrix
MSC differentiation to osteogenic lineage
Osteocalcin,
Alkaline
phosphatase,
Runx2,
Dlx5, Osterix
Ex- vivo
Ascorbate, β-glycerol phosphate, dex
MSCs
Day 0 4 6……………………………………………………………..21
Transcription factors network in osteoblastogenesis
Dlx3
• BMP2 function in skeletal lineage
PLK0-GFP shBMP2
C= control
NT= NT shRNA
Toxicity
Alizarin Red
staining
Can the phenotype be rescued with other osteoinductive
protein- BMP7 ?
Regulation of transcription factor network by BMP7
EF1α-Luc
CMV-LacZ
Lentiviral shBMP2 diminishes trabecular bone formation
Micro-CT
Loss of BMP2 blocks regeneration of new bone formation
BMP2 affects downstream transcription factors
BMP2 does not affect stem cell recruitment
Bais MV, Wigner N, Young M, Toholka R, Graves DT, Morgan EF, Gerstenfeld
LC and Einhorn TA BMP-2 Is Essential for Post Natal Osteogenesis but not
for Recruitment of Osteogenic Stem Cells (Manuscript : Bone).
Interim conclusion
Ariad Inc.
30000
CMV-TF mice
20000
10000
0 Day 21
No diamerizer 5uM dimerizer
AP21967 AP21967
3000 CMV-TF X Ind – Luc mice
2000
1000000 Ind-Luc mice
500000 1000
0 0
No diamerizer 5uM dimerizer control bone spleen kidney lung liver mix all
AP21967 AP21967 tissues
Inducible BMP2 expression produces specific
phenotype- like osteoporosis??
Non-injured bone
0.1
Connection density
Fracture callus
Trabecular thickness
100 1
50
0 0
vehicle tr eated r apamycin tr eated BMP2 X CMV control- No Transgenic BMP2 with
Rapamycin (n=5 ) rapamycin (n=5 )
Conclusions:
Fixed by intrameduallary
Roding
Tissues and cell type that contribute to repair
Initial Injury Endochondral Phase Primary Bone Formation Secondary Bone Formation
60 4
30 2
0 0
0 1 3 5 7 10 14 10 12 14 16 21
Days After Fracture Days After Plating
Nanog gene is functional in post-natal cells
Fold change nanog mRNA
1.5
5' nanog promoter (2.5Kb) active in W20-17 cells
0.5
20000
activity
0.07
0
NTshRNA Nanog 336 shRNA 10000
0
Fold change osteocalcin mRNA
l1
l2
l3
3
st
st
st
ro
ro
ro
te
te
te
nt
nt
nt
co
co
co
8
0
NT shRNA Nanog 336 shRNA
Loss of Nanog upregulate the genes related to
differentiation in vivo at day 7
3.00
2.00
1.00
0.00
Nanog shRNA NT shRNA
Riken,
Japan
Question:
Oligonuclotide-
vero cells
Antibody- CEFs
primary cells
CMV-GFP plasmid
vero cells
Bais MV, Kumar S, Tiwari AK, Kataria RS, Nagaleekar VK, Shrivastava S, Chindera K. Novel Rath peptide for intracellular
delivery of protein and nucleic acids.Biochem Biophys Res Commun. 2008 May 23;370(1):27-32. Epub 2008 Mar 17.
PMID: 18346454.
Structural characterization of Rath peptide
CD spectroscopy
Fluorescence
spectroscopy
Transmission
Electron
Microscopy
Orthopedic Surgery Lab
Thomas Einhorn, MD
Louis Gerstenfeld, PhD
Jody McLean, BS
Zabrina Shabin, BS
Nathan Wigner , BS (MD/PhD)
Megan Yang, MD
Collaborators:
Philip Trackman, PhD
Darrell Kotton, MD
Temple Smith, PhD
Dana Graves, DMD, DMSc
Elise Morgan, PhD